Interview with Louis Hodossy, General Manager, Roche Hungary
Hungary has been recognized as one of the largest pharmaceutical and healthcare markets in Central and Eastern…
Roche Hungary
Last updated: 01.06.2015
Address: Budaörs 2040 Edison u. 1. Hungary,Hungary
Tel: +36-23-446-871
Web: http://www.roche-diagnostics.hu/portal/dia/rolunk
Company description
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80’000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.
Products and services
Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.
Interviews
Related
Chronic Disease in Hungary: An Ounce of Prevention
Preventive healthcare and health literacy are core issues in Hungary that, if left unaddressed, may hinder the…
Unconventional Channels for OTC in Hungary: The Path Less Traveled
Smaller pharma companies in Hungary are looking to new unconventional methods of OTC promotion to sidestep the…
Interview: Dr. József Timár – President of Doctoral Council, Semmelweis…
The President of the Doctoral Council of Semmelweis University, Dr. József Timár provides an overview of the…
Interview: Andrea Bondar – Country Manager, LEO Pharma Hungary
LEO Pharma Hungary’s Andrea Bondár demonstrates the significance of adopting non-traditional methods of…
Interview: Anita Ordog – Managing Director, Angelini Hungary
Anita Ordog, GM of Angelini Hungary, discusses the affiliate’s history in the country, their expanding OTC and…
Interview: Dr. Lívia Ilku – Director, MAGYOSZ, Hungary
Dr. Lívia Ilku, director of Hungary’s main domestic pharmaceutical manufacturers’ association (MAGYOSZ),…
Interview: Prof. Dr. István Vályi-Nagy – Director General, United St.…
Prof. Dr. István Vályi-Nagy, Director General of the United St. Istvan and St. Laszlo Hospitals, shares his…
Interview: Ákos Tóth – Managing Director, HUMAN BioPlazma, Hungary
The Managing Director of HUMAN BioPlazma, Ákos Tóth, highlights the transformational growth that the business has…
Interview: Dr. Judit Bidló – Head of Pricing Support, OEP, Hungary
Providing universal health coverage to the nation’s roughly 10 million citizens, Hungary’s National Health…
Health Equals Wealth in Hungary
Chronic underfinancing is a common pitfall for many former socialist states and Hungary is no exception. Total…
Interview: Tamas Uri – Country Manager, Mylan Hungary
Mylan Hungary’s Tamas Uri discusses transitioning into both a branded and generic business dedicated…
Interview: Péter Szijjártó – Minister of Foreign Affairs & Trade,…
Hungary’s Minister of Foreign Affairs and Trade Péter Szijjártó highlights the significant role that foreign…
